Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Horizon Therapeutics Public LTD CO Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $22.7 Million - $33.3 Million	-286,497 Reduced 66.59%	143,771 $11.5 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $7.8 Million - $9.48 Million	79,097 Added 22.52%	430,268 $46.6 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $19 Million - $22.8 Million	206,467 Added 142.68%	351,171 $38.5 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $7.77 Million - $8.64 Million	90,040 Added 164.72%	144,704 $13.6 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $3.93 Million - $5.22 Million	54,664 New	54,664 $5.03 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account